Oat protein isolate-<i>Pleurotus ostreatus</i> β-glucan conjugate nanoparticles bound to β-carotene effectively alleviate immunosuppression by regulating gut microbiota-Reference-Cited by-同舟云学术

Oat protein isolate-Pleurotus ostreatus β-glucan conjugate nanoparticles bound to β-carotene effectively alleviate immunosuppression by regulating gut microbiota

Published:2024 Issue:4 Volume:15 Page:1867-1883
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Zhong Lei¹,Hu Qiuhui²^ORCID,Zhan Qiping¹^ORCID,Zhao Mingwen³,Zhao Liyan¹^ORCID

Affiliation:

1. College of Food Science and Technology, Nanjing Agricultural University, Nanjing, 210095, P.R. China

2. College of Food Science and Engineering, Nanjing University of Finance and Economics/Collaborative Innovation Center for Modern Grain Circulation and Safety, Nanjing, 210023, P.R. China

3. Key Laboratory of Agricultural Environmental Microbiology, Ministry of Agriculture; Microbiology Department, College of Life Sciences, Nanjing Agricultural University, Nanjing, 210095, P.R. China

Abstract

β-carotene-loaded nanoparticles, stabilized by Maillard-type oat protein isolate-Pleurotus ostreatus β-glucan conjugates, can mitigate immunosuppression through the regulation of gut microbiota.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

China Postdoctoral Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/FO/D3FO05158G

Reference103 articles.

1. Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy

2. Author Correction: Cycloalkane-modified amphiphilic polymers provide direct extraction of membrane proteins for CryoEM analysis

3. The gut microbiota is associated with immune cell dynamics in humans

4. High C-Terminal Cross-Linking Telopeptide of Collagen Type-I (CTX) Predicts for Poor Overall Survival in Patients with Multiple Myeloma Who Receive Frontline Therapy with Immunomodulatory Drugs (IMiDs) but Not with Bortezomib-Based Regimens

5. Biotechnology advances in β-carotene production by microorganisms